Early effects of oral administrations of lafutidine with mosapride on intragastric pH

Trial Profile

Early effects of oral administrations of lafutidine with mosapride on intragastric pH

Completed
Phase of Trial: Phase I

Latest Information Update: 13 May 2016

At a glance

  • Drugs Lafutidine (Primary) ; Mosapride (Primary)
  • Indications Gastro-oesophageal reflux; Gastrointestinal ulcer; Peptic ulcer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Aug 2009 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 12 Aug 2009 Actual initiation date (Sep 2008) added as reported by University Hospital Medical Information Network - Japan record.
    • 18 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top